New hope for transplant patients: can a common pill sharpen blood sugar control?
NCT ID NCT07228195
Summary
This study is testing if adding the diabetes drug empagliflozin helps people who have received a transplant of their own insulin-producing cells. It will involve 40 adults who still have some cell function after their transplant. Researchers will compare different doses of the drug to see which one best improves time spent in a healthy blood sugar range over three months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.